Topics

Glioblastoma | Treatment | Clinical trials | Positron emission tomography

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Positron emission tomography

Progression

Lakomý R, Lojová M, Souckova L, Hynkova L, Polachova K, Vasina J, Demlová R, Poprach A, Sana J, Prochazka T, Smrcka M, Fadrus P, Jancalek R, Selingerova I, Belanova R, Slampa P, Pospisil P, Kazda T.
¹¹C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET).
BMC Cancer. 2024 Jun 15;24(1):736. doi: 10.1186/s12885-024-12469-2. PMID: 38879476. Interventional study protocol. ˍ

Pseudoprogression

Ruijters VJ, Snijders TJ, van der Pol JAJ, van de Giessen EM, Niers JM, Broen MPG, Anten MM, van Zanten SEMV, Geurts M, Arens AIJ, Henssen DJHA, Gijtenbeek JM, van der Meulen M, Sijben AEJ, Ghariq E, Vos MJ, Tim J, Bosma IB, Stormezand GN, Frederix GWJ, Dankbaar JW, Robe PA, Verhoeff JJC, de Vos FYFL, Lam MGEH, Ten Ham RMT, Tolboom N.
[¹⁸F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.
Trials. 2025 Jun 17;26(1):208. doi: 10.1186/s13063-025-08921-8. PMID: 40528226. Interventional study protocol. ˍ